 Stefanie Kennon-Mcgill
Concepts (123)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlea | 3 | 2019 | 19 | 0.940 |
Why?
| | Acetaminophen | 8 | 2023 | 283 | 0.780 |
Why?
| | Cannabidiol | 4 | 2023 | 37 | 0.700 |
Why?
| | Pharmaceutical Preparations | 1 | 2019 | 77 | 0.630 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 138 | 0.590 |
Why?
| | Plant Extracts | 4 | 2020 | 190 | 0.470 |
Why?
| | Liver | 6 | 2020 | 1115 | 0.400 |
Why?
| | Cannabis | 4 | 2023 | 145 | 0.390 |
Why?
| | Liver Regeneration | 2 | 2019 | 49 | 0.310 |
Why?
| | Alanine Transaminase | 4 | 2023 | 124 | 0.310 |
Why?
| | Drug Overdose | 3 | 2020 | 159 | 0.290 |
Why?
| | Child Development | 2 | 2018 | 190 | 0.260 |
Why?
| | Mice, Inbred C57BL | 6 | 2020 | 1816 | 0.250 |
Why?
| | Liver Diseases | 1 | 2023 | 78 | 0.210 |
Why?
| | Mice | 7 | 2023 | 5739 | 0.210 |
Why?
| | Animals | 11 | 2023 | 13187 | 0.200 |
Why?
| | Liver Failure, Acute | 1 | 2022 | 54 | 0.200 |
Why?
| | Phosphatidic Acids | 2 | 2019 | 8 | 0.200 |
Why?
| | Cytochrome P-450 Enzyme System | 2 | 2020 | 195 | 0.200 |
Why?
| | End Stage Liver Disease | 1 | 2022 | 44 | 0.200 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2021 | 117 | 0.180 |
Why?
| | Biological Transport, Active | 1 | 2019 | 30 | 0.170 |
Why?
| | Hepatic Veno-Occlusive Disease | 1 | 2019 | 10 | 0.170 |
Why?
| | Sulfotransferases | 1 | 2019 | 40 | 0.170 |
Why?
| | Xenobiotics | 1 | 2019 | 30 | 0.170 |
Why?
| | Glycerol-3-Phosphate O-Acyltransferase | 1 | 2019 | 5 | 0.170 |
Why?
| | ortho-Aminobenzoates | 1 | 2019 | 8 | 0.170 |
Why?
| | Anti-Obesity Agents | 1 | 2019 | 19 | 0.170 |
Why?
| | Liver Cirrhosis | 1 | 2021 | 218 | 0.160 |
Why?
| | Tea | 1 | 2019 | 30 | 0.160 |
Why?
| | Phosphatidate Phosphatase | 1 | 2018 | 11 | 0.160 |
Why?
| | Glucuronosyltransferase | 1 | 2019 | 126 | 0.160 |
Why?
| | Videotape Recording | 1 | 2018 | 28 | 0.160 |
Why?
| | Hepatocytes | 1 | 2019 | 182 | 0.150 |
Why?
| | Sulfonamides | 1 | 2019 | 129 | 0.150 |
Why?
| | Kinetics | 1 | 2019 | 623 | 0.150 |
Why?
| | Social Behavior | 1 | 2018 | 72 | 0.150 |
Why?
| | Fixation, Ocular | 1 | 2017 | 13 | 0.150 |
Why?
| | Bacteria | 1 | 2019 | 224 | 0.150 |
Why?
| | Face | 1 | 2017 | 60 | 0.140 |
Why?
| | Gene Expression | 1 | 2019 | 609 | 0.140 |
Why?
| | Interpersonal Relations | 1 | 2017 | 105 | 0.140 |
Why?
| | Oxidative Stress | 2 | 2023 | 770 | 0.140 |
Why?
| | Attention | 1 | 2017 | 175 | 0.140 |
Why?
| | Nuclear Proteins | 1 | 2018 | 242 | 0.140 |
Why?
| | Communication | 1 | 2018 | 246 | 0.130 |
Why?
| | Autistic Disorder | 1 | 2017 | 119 | 0.130 |
Why?
| | Hair Cells, Auditory | 1 | 2015 | 5 | 0.130 |
Why?
| | Signal Transduction | 2 | 2022 | 1618 | 0.130 |
Why?
| | Sound | 1 | 2015 | 11 | 0.130 |
Why?
| | Hearing | 1 | 2016 | 59 | 0.130 |
Why?
| | Hearing Loss, Noise-Induced | 1 | 2015 | 10 | 0.130 |
Why?
| | Male | 10 | 2021 | 25241 | 0.100 |
Why?
| | Infant | 3 | 2023 | 3567 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 1376 | 0.060 |
Why?
| | Female | 6 | 2023 | 26472 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2019 | 1455 | 0.060 |
Why?
| | Alanine | 1 | 2023 | 42 | 0.060 |
Why?
| | Pyruvic Acid | 1 | 2023 | 22 | 0.060 |
Why?
| | Humans | 7 | 2023 | 49974 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2023 | 322 | 0.050 |
Why?
| | Glutathione | 1 | 2023 | 295 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2022 | 65 | 0.050 |
Why?
| | Glutamate Dehydrogenase | 1 | 2021 | 16 | 0.050 |
Why?
| | HMGB1 Protein | 1 | 2021 | 17 | 0.050 |
Why?
| | Keratin-18 | 1 | 2021 | 15 | 0.050 |
Why?
| | Antioxidants | 1 | 2023 | 249 | 0.050 |
Why?
| | Rats | 2 | 2020 | 3305 | 0.050 |
Why?
| | Taurine | 1 | 2020 | 15 | 0.050 |
Why?
| | Herb-Drug Interactions | 1 | 2020 | 31 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 376 | 0.050 |
Why?
| | Toxicity Tests | 1 | 2020 | 52 | 0.050 |
Why?
| | Alkaline Phosphatase | 1 | 2020 | 94 | 0.040 |
Why?
| | Young Adult | 2 | 2021 | 3958 | 0.040 |
Why?
| | Adenosylhomocysteinase | 1 | 2020 | 10 | 0.040 |
Why?
| | Alcohol Dehydrogenase | 1 | 2020 | 38 | 0.040 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2020 | 26 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 223 | 0.040 |
Why?
| | Glutamine | 1 | 2020 | 171 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2019 | 47 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2019 | 161 | 0.040 |
Why?
| | Proteomics | 1 | 2022 | 329 | 0.040 |
Why?
| | Child, Preschool | 2 | 2018 | 3871 | 0.040 |
Why?
| | Drug Synergism | 1 | 2019 | 150 | 0.040 |
Why?
| | Thinness | 1 | 2019 | 46 | 0.040 |
Why?
| | Pilot Projects | 1 | 2021 | 699 | 0.040 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2019 | 75 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2022 | 945 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 176 | 0.040 |
Why?
| | beta Catenin | 1 | 2019 | 102 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2018 | 77 | 0.040 |
Why?
| | Endophenotypes | 1 | 2017 | 5 | 0.040 |
Why?
| | Twins, Dizygotic | 1 | 2017 | 7 | 0.040 |
Why?
| | Twins, Monozygotic | 1 | 2017 | 17 | 0.040 |
Why?
| | Dexamethasone | 1 | 2020 | 430 | 0.040 |
Why?
| | Eye | 1 | 2017 | 31 | 0.040 |
Why?
| | Phosphorylation | 1 | 2019 | 535 | 0.040 |
Why?
| | Siblings | 1 | 2017 | 34 | 0.040 |
Why?
| | Mouth | 1 | 2017 | 33 | 0.040 |
Why?
| | Prognosis | 1 | 2022 | 1942 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2020 | 443 | 0.040 |
Why?
| | Transcriptome | 1 | 2019 | 315 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 391 | 0.030 |
Why?
| | Glutathione Disulfide | 1 | 2016 | 41 | 0.030 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2015 | 1 | 0.030 |
Why?
| | Hair Cells, Auditory, Outer | 1 | 2015 | 1 | 0.030 |
Why?
| | Tissue Preservation | 1 | 2015 | 7 | 0.030 |
Why?
| | Plastics | 1 | 2015 | 11 | 0.030 |
Why?
| | Rats, Long-Evans | 1 | 2015 | 26 | 0.030 |
Why?
| | Noise | 1 | 2015 | 39 | 0.030 |
Why?
| | Auditory Threshold | 1 | 2015 | 49 | 0.030 |
Why?
| | Prospective Studies | 1 | 2021 | 2364 | 0.030 |
Why?
| | Pregnancy | 1 | 2023 | 2607 | 0.030 |
Why?
| | Middle Aged | 2 | 2021 | 12069 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2019 | 1007 | 0.030 |
Why?
| | Risk Assessment | 1 | 2019 | 1259 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1032 | 0.030 |
Why?
| | Protein Binding | 1 | 2016 | 660 | 0.030 |
Why?
| | Adult | 2 | 2021 | 13236 | 0.030 |
Why?
| | United States | 1 | 2023 | 4860 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2015 | 1193 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 3129 | 0.020 |
Why?
| | Aged | 1 | 2018 | 9310 | 0.010 |
Why?
|
|
Kennon-Mcgill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|